PNC Financial Services Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.8K Buy
6,041
+3,537
+141% +$11.2K ﹤0.01% 3841
2025
Q4
$10K Buy
2,504
+2,175
+661% +$12.1K ﹤0.01% 3949
2025
Q3
$2.78K Sell
329
-135
-29% -$1.31K ﹤0.01% 4407
2025
Q2
$5.22K Buy
464
+161
+53% +$1.48K ﹤0.01% 4114
2025
Q1
$2.87K Sell
303
-112
-27% -$1.13K ﹤0.01% 4247
2024
Q4
$4.67K Sell
415
-131
-24% -$2.3K ﹤0.01% 4058
2024
Q3
$15.4K Buy
546
+445
+441% +$11.5K ﹤0.01% 3628
2024
Q2
$1.93K Sell
101
-4,953
-98% -$126K ﹤0.01% 4261
2024
Q1
$166K Buy
5,054
+4,548
+899% +$145K ﹤0.01% 2303
2023
Q4
$16.7K Buy
506
+67
+15% +$1.9K ﹤0.01% 3531
2023
Q3
$12K Sell
439
-105
-19% -$2.92K ﹤0.01% 3669
2023
Q2
$16.5K Sell
544
-269
-33% -$8.7K ﹤0.01% 3635
2023
Q1
$26.4K Sell
813
-69
-8% -$2.18K ﹤0.01% 3361
2022
Q4
$24.8K Sell
882
-41
-4% -$1.18K ﹤0.01% 3362
2022
Q3
$34K Buy
923
+537
+139% +$18.9K ﹤0.01% 3182
2022
Q2
$12K Buy
386
+113
+41% +$3.29K ﹤0.01% 3721
2022
Q1
$9K Buy
273
+185
+210% +$4.84K ﹤0.01% 3850
2021
Q4
$3K Sell
88
-431
-83% -$12.4K ﹤0.01% 4063
2021
Q3
$16K Buy
519
+394
+315% +$9.46K ﹤0.01% 3592
2021
Q2
$3K Buy
125
+102
+443% +$2.04K ﹤0.01% 3978
2021
Q1
$0 Hold
23
﹤0.01% 4134
2020
Q4
$0 Hold
23
﹤0.01% 3991
2020
Q3
$0 Sell
23
-28
-55% -$329 ﹤0.01% 3954
2020
Q2
$0 Sell
51
-6,958
-99% -$46.6K ﹤0.01% 3949
2020
Q1
$37K Hold
7,009
﹤0.01% 2794
2019
Q4
$64K Hold
7,009
﹤0.01% 2747
2019
Q3
$50K Buy
7,009
+23
+0.3% +$165 ﹤0.01% 2908
2019
Q2
$55K Sell
6,986
-8,700
-55% -$103K ﹤0.01% 2885
2019
Q1
$197K Sell
15,686
-3,074
-16% -$48.7K ﹤0.01% 2155
2018
Q4
$373K Buy
18,760
+5,601
+43% +$130K ﹤0.01% 1707
2018
Q3
$373K Buy
13,159
+4,908
+59% +$117K ﹤0.01% 1839
2018
Q2
$174K Buy
8,251
+907
+12% +$17.2K ﹤0.01% 2269
2018
Q1
$105K Sell
7,344
-8,078
-52% -$116K ﹤0.01% 2526
2017
Q4
$191K Buy
15,422
+5,065
+49% +$71.4K ﹤0.01% 2220
2017
Q3
$184K Hold
10,357
﹤0.01% 2187
2017
Q2
$262K Buy
10,357
+7,357
+245% +$177K ﹤0.01% 1983
2017
Q1
$67K Hold
3,000
﹤0.01% 2743
2016
Q4
$44K Buy
3,000
+1,000
+50% +$19.7K ﹤0.01% 2887
2016
Q3
$49K Hold
2,000
﹤0.01% 2819
2016
Q2
$38K Hold
2,000
﹤0.01% 2953
2016
Q1
$21K Hold
2,000
﹤0.01% 3259
2015
Q4
$24K Hold
2,000
﹤0.01% 3200
2015
Q3
$32K Buy
+2,000
New +$39K ﹤0.01% 3131

Other funds holding EVH

PNC Financial Services Group's EVH Position: Q1 2026 in Review

PNC Financial Services Group increased its Evolent Health (EVH) stake by 141% in Q1 2026, buying an estimated $11.2K and bringing the position to 6,041 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

PNC Financial Services Group first reported a position in EVH in Q3 2015 and has held it in 43 quarters since. The position peaked at $373K in Q4 2018. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • PNC Financial Services Group held 6,041 shares of Evolent Health worth $13.8K as of Q1 2026.
  • PNC Financial Services Group bought 3,537 Evolent Health shares in Q1 2026, an estimated $11.2K.
  • Evolent Health made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3841 holding.
  • PNC Financial Services Group first reported a position in Evolent Health in Q3 2015 and has held it in 43 quarters since.
  • PNC Financial Services Group's Evolent Health position peaked at $373K in Q4 2018.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.